← SynDRA
KU-C103428N
SynDRA canonical compound SYN0086561 — structure-anchored drug synonym record
| Primary target(s) | NFE2 |
|---|
| Mechanism of action | Rho associated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CDC inhibitor
- Rho associated kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- ALDH1A1
- AURKA
- BRD4
- BRPF1
- CSNK1D
- EHMT2
- FGFR3
- GSK3B
- MAPK1
- RGS4
- SMN1
- TDP1
- TRIM24
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CCNA2
- CCNB1
- CCNE1
- CCNH
- CCNT1
- CDK1
- CDK5R1
- CDK7
- CDK9
- MNAT1
Cross-references
Synonyms
- KUC103428N
- MLS002699037
- UNM-0000306147
- SMR001544250
- MLS002630928
- SCHEMBL18826377
- BDBM54652
- CHEBI:91897
- cid_44143703
- HMS3102A14
- 4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
Look up KU-C103428N in the interactive SynDRA portal →